Vaccine Development
Anti-TNF antibodies are the focus of review
Published in Vaccine Weekly, June 14th, 2006
According to the review, "TNF-alpha is a pivotal cytokine with pleiotropic effects in the innate and adaptive immune systems. Clinically, two strategies have been developed to neutralize it: monoclonal anti-TNF-alpha antibodies and a recombinant protein containing the p75 receptor."
Thierry Martin at INSERM U737 in Strasbourg wrote, "These products have been shown to be remarkably efficacious in the treatment of certain autoimmune and inflammatory conditions, in particular, in rheumatoid arthritis,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-06-14)
More Articles from Vaccine Weekly
- Addiction Medicine
Bivalent morphine/heroin vaccine prevents relapse to heroin addiction - Dengue Vaccine
Fusion protein dengue vaccine is protective in nonhuman primates - Human Papillomavirus Vaccine
Parental acceptance of adolescent HPV vaccine is critical for success - Influenza Vaccine
Influenza A NP-expressing vaccinia virus protects against human and avian influenza - Influenza Vaccine
Influenza vaccine containing A/Panama/1999 induces broad protection against influenza - Adenovirus Vaccine
Adenoviral respiratory illness in U.S. military recruits is increasing - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
